TickerFacts.

IB Acquisition Corp. (IBAC): Shareholders' Equity

Annual figures by period end, from SEC filings.

-$681.3K
As of 2025-09-30
-$2.31M
As of 2026-06-30
$1.11M2023-09-30: -$5.4K2024-09-30: $1.11M2025-09-30: -$681.3K-$681.3K
2023-09-30 Shareholders' Equity (USD) 2025-09-30
Period endedShareholders' EquityChange YoYSource filing
2025-09-30-$681.3Kn/m2025-12-29, Balance as of period end
2024-09-30$1.11Mn/m2025-12-29, Balance as of period end
2023-09-30-$5.4Kn/a2024-12-26, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
IB Acquisition Corp. (IBAC)2025-09-30-$681.3Kn/m
bioAffinity Technologies, Inc. (BIAF)2025-12-31$7.28M+179.7%
iSpecimen Inc. (ISPC)2025-12-31$3.09M-6.7%
Foxo Technologies Inc. (FOXO)2025-12-31$11.14M+109.3%
NRC Health (NRC)2025-12-31$13.99M-55.3%
OneMedNet Corp (ONMD)2025-12-31-$2.96Mn/m
MaxCyte, Inc. (MXCT)2025-12-31$171.49M-16.9%
Absci Corp (ABSI)2025-12-31$189.45M+5.8%
OmniAb, Inc. (OABI)2025-12-31$267.03M-7.2%

Compare IBAC, BIAF, ISPC, FOXO side by side · Screen every company in Services-Commercial Physical & Biological Research ↗